 Connection
Santanu Samanta to Humans
This is a "connection" page, showing publications Santanu Samanta has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.051 |
|
|
|
-
Slater NN, Farsi S, Rogers AL, Herberger L, Penagaricano J, McKee S, King D, Samanta S, Sunde J, Vural E, Moreno MA. Reirradiation in head and neck squamous cell carcinoma; prognostic indicators, oncologic and functional outcomes. Am J Otolaryngol. 2024 Nov-Dec; 45(6):104482.
Score: 0.009
-
Megahed R, Prabhu AV, Mack DP, Gholami S, Samanta S, Patel M, Lewis GD. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series. Oral Oncol. 2024 May; 152:106778.
Score: 0.009
-
Nichols M, Kesaria A, Spencer HJ, Williams HR, Samanta S, Lewis GD. Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center. Anticancer Res. 2024 Jan; 44(1):151-155.
Score: 0.009
-
Prabhu AV, Peterman M, Kesaria A, Samanta S, Crownover R, Lewis GD. Virtual reality technology: A potential tool to enhance brachytherapy training and delivery. Brachytherapy. 2023 Nov-Dec; 22(6):709-715.
Score: 0.009
-
Leiser D, Samanta S, Eley J, Strauss J, Creed M, Kingsbury T, Staats PN, Bhandary B, Chen M, Dukic T, Roy S, Mahmood J, Vujaskovic Z, Shukla HD. Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer. PLoS One. 2021; 16(11):e0258951.
Score: 0.008
-
Das A, Mahapatra S, Bandyopadhyay D, Samanta S, Chakraborty S, Philpotts LL, Jahangir E, Roy B. Bleeding with vascular endothelial growth factor tyrosine kinase inhibitor: A network meta-analysis. Crit Rev Oncol Hematol. 2021 Jan; 157:103186.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|